Your browser doesn't support javascript.
loading
The Neuropeptide Y1 Receptor Ligand-Modified Cell Membrane Promotes Targeted Photodynamic Therapy of Zeolitic Imidazolate Frameworks for Breast Cancer.
Wang, Yinjie; Cao, Yi; Jiang, Zhenqi; Li, Yanying; Yuan, Bo; Xing, Jie; Li, Mingli; Gao, Qianqian; Xu, Kaiwei; Akakuru, Ozioma Udochukwu; Wu, Aiguo; Li, Juan.
Affiliation
  • Wang Y; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Cao Y; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Jiang Z; University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
  • Li Y; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Yuan B; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Xing J; University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
  • Li M; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Gao Q; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Xu K; University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
  • Akakuru OU; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Wu A; Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, CAS Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering,
  • Li J; Department of Radiology, Affiliated Hospital of Medical School of Ningbo University, Ningbo University School of Medicine, Ningbo 315010, P. R. China.
J Phys Chem Lett ; 12(46): 11280-11287, 2021 Nov 25.
Article in En | MEDLINE | ID: mdl-34767373
ABSTRACT
Zeolitic imidazolate frameworks (ZIFs), widely regarded as promising materials for application in catalysis and separation, hold an increasingly significant position in drug delivery systems for their high drug loading capacity. Focused specifically on the rational design of targeting and bioresponsive nanovehicles, a neuropeptide Y1 receptor ligand (Y1L)-modified cell membrane camouflaged bioresponsive ZIF system (Y1L-RBC@ZIF-90@Ce6) was constructed for targeted photodynamic therapy of breast cancer. The biomimetic ZIF-based nanocarrier enhanced tumor accumulation by both neuropeptide Y1 receptor-targeted guidance and long-term stability. Y1L served as a good ligand-mediated selective targeting molecule for breast cancer, and red blood cell membrane-camouflaged nanocomposites displayed favorable biocompatibility. With the dual response of the ZIF to pH and adenosine triphosphate, the stimulus responsive photosensitizer Chlorin e6 delivery system effectively suppressed tumors in vivo. This work offers a platform for developing much safer and more efficient photodynamic therapy for the treatment of Y1R-overexpressed breast cancer.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Breast Neoplasms / Receptors, Neuropeptide Y / Photosensitizing Agents / Antineoplastic Agents Type of study: Guideline Limits: Humans Language: En Journal: J Phys Chem Lett Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Breast Neoplasms / Receptors, Neuropeptide Y / Photosensitizing Agents / Antineoplastic Agents Type of study: Guideline Limits: Humans Language: En Journal: J Phys Chem Lett Year: 2021 Document type: Article